What is it about?

This work described for the first time a collection of clinical strains of Pseudomonas aeruginosa overproducing the efflux system MexEF-OprN which accounts for resistance to chloramphenicol, trimethoprim and fluoroquinolones antibiotics. We explored the genetic events responsible for MexEF-OprN overproduction and found that most of these clinical strains harbor single amino acid substitutions in protein MexS. This substitutions probably alter the enzymatic activity of MexS which could serve as positive signal to pump production. We also found that for nearly half of these strains, any of the genes known to regulate mexEF-oprN efflux operon is mutated or altered indirectly showing that there are still unknown loci capable to activate this operon.

Featured Image

Why is it important?

Characterization of multi-drug resistant strains is necessary to understand which mechanisms participate in this phenotype. The pump MexEF-OprN was discovered in 1997 and even if its contribution to antibiotic resistance among clinical strains of Pseudomonas aeruginosa had already been investigated, the molecular mechanisms giving rise to the pump overproduction has been poorly studied.

Perspectives

Working with clinical strains of Pseudomonas aeruginosa is a real challenge. This work allowed us not only to screen a large collection of 221 clinical strains presenting a carbapenem/ciprofloxacin cross-resistance profile but to identified among these strains 43 isolates overproducing the efflux system MexEF-OprN. Further characterization of these strains allowed us to identify that the most frequent genetic event responsible for MexEF-OprN overproduction was the modification of the enzyme MexS by single amino acid substitutions. We also found out that for nearly half of these strains, any of the genes known to regulate mexEF-oprN operon is altered or mutated, indirectly showing that there are still unkknown loci capable to activate the efflux operon.

Paulo Juarez
Universite de Franche-Comte

Read the Original

This page is a summary of: Amino Acid Substitutions Account for Most MexS Alterations in ClinicalnfxCMutants of Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, February 2016, ASM Journals,
DOI: 10.1128/aac.02622-15.
You can read the full text:

Read

Contributors

The following have contributed to this page